This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Amanda Barefoot, MHA, Managing Director, Health Care & LifeSciences Solutions AIs intention is to alleviate provider burden, but law making could increase it. With over 60% of healthcare and lifesciences executives already leveraging AI in production, we are witnessing a significant shift towards AI-powered solutions.
Notwithstanding mass adoption of antivirus protection and firewalls among healthcareproviders, there remains a security gap for biomedical technologies, according to a report from Zingbox. The more connected nodes in healthcare, the more temptations and opportunities for cyber-attackers to attack.
What You Should Know: – Salesforce announced the general availability of LifeSciences Cloud , a platform for pharmaceutical ( pharma ) and medicaltechnology ( medtech ) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI.
Building on this commitment, were excited to introduce new features in our AI healthcare portfolio that will further drive industry efficiencies, and better patient outcomes. In 2024, we announced the launch of healthcare AI models , a collection of cutting-edge multimodal medical imaging foundation models available in Azure AI Foundry.
With this in mind, it is critical that both payers and providers in VBC arrangements consider how their data flows through the entire system so that key partners, such as lifesciences and pharmaceutical companies – have real-world insights (RWI) about the impact their medication is having on outcomes.
In the past few months, she’s traveled to Australia and Ireland, for example, to spread her knowledge about digital health and technology to healthcareproviders, investors, and innovators. Lisa’s also a frequent public speaker, in both the U.S. and globally.
Conducting pilot studies, gathering real-world evidence, and collaborating with healthcareproviders can build a strong value proposition to entice investors. Her expertise spans virtual twin technology, clinical trial software, digital health, and medical device manufacturing.
Ivor Campbell, CEO of Snedden Campbell The global landscape for medicaltechnology, biotechnology, and lifesciences is on the cusp of seismic change. The broad lifescience industry too is in the midst of a period of significant transition.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content